B. Hartmann

Increasing test specificity without impairing sensitivity: lessons learned from SARS-CoV-2 serology

T. Koller, F. Grebien, H. Haslacher, 2022, Journal of clinical pathology.

Spike Protein Antibodies Mediate the Apparent Correlation between SARS-CoV-2 Nucleocapsid Antibodies and Neutralization Test Results

H. Haslacher, T. Koller, C. Binder, 2021, medRxiv.

One-Year Follow-Up of COVID-19 Patients Indicates Substantial Assay-Dependent Differences in the Kinetics of SARS-CoV-2 Antibodies

A. Griesmacher, S. Sahanic, T. Sonnweber, 2022, Microbiology spectrum.

The sensitivity improved two-test algorithm “SIT2”: a universal optimization strategy for SARS-CoV-2 serology

T. Koller, F. Grebien, H. Haslacher, 2020 .

A comprehensive antigen production and characterisation study for easy-to-implement, specific and quantitative SARS-CoV-2 serotests

N. Borth, A. Griesmacher, B. Dieplinger, 2021, EBioMedicine.

Clinical validation of the Siemens quantitative SARS-CoV-2 spike IgG assay (sCOVG) reveals improved sensitivity and a good correlation with virus neutralization titers

A. Griesmacher, W. Prokop, M. Anliker, 2021, Clinical chemistry and laboratory medicine.

Clinical validation of the quantitative Siemens SARS-CoV-2 spike IgG assay (sCOVG) reveals improved sensitivity and a good correlation with virus neutralization titers

A. Griesmacher, W. Prokop, M. Anliker, 2021, medRxiv.

Borderline and weakly positive antibody levels against the S-protein of SARS-CoV-2 exhibit limited agreement with virus neutralization titres

A. Griesmacher, W. Prokop, M. Anliker, 2021, Journal of Clinical Virology Plus.